Rescue therapy after Helicobacter pylori eradication failure;Tratamientos de rescate ante el fracaso erradicador de

Gastroenterologia y Hepatologia

Volumn 34, Issue 2, 2011, Pages 89-99

  Gisbert, Javier P ^a  

^a HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

Author keywords

Clarithromycin; Failure; Helicobacter pylori; Levofloxacin; Metronidazole; Rescue; Rifabutin

Indexed keywords

AMOXICILLIN; BISMUTH; CLARITHROMYCIN; ESOMEPRAZOLE; LANSOPRAZOLE; LEVOFLOXACIN; METRONIDAZOLE; OMEPRAZOLE; PANTOPRAZOLE; PROTON PUMP INHIBITOR; RIFABUTIN; TETRACYCLINE;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM CULTURE; DRUG EFFICACY; DRUG TOLERABILITY; ERADICATION THERAPY; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; TREATMENT FAILURE;

ANTI-BACTERIAL AGENTS; DRUG THERAPY, COMBINATION; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; PROTON PUMP INHIBITORS; TREATMENT FAILURE;

EID: 79952054420     PISSN: 02105705     EISSN: 15789519     Source Type: Journal    
DOI: 10.1016/j.gastrohep.2010.10.013     Document Type: Article

References (53)

1. Malfertheiner P., Megraud F., O'Morain C., Bazzoli F., El-Omar E., Graham D., et al. Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report. Gut. 2007, 56:772-781.
2. Gisbert J.P., Gonzalez L., Calvet X., Garcia N., Lopez T., Roque M., et al. Proton pump inhibitor, clarithromycin and either amoxycillin or nitroimidazole:a meta-analysis of eradication of Helicobacter pylori. Aliment Pharmacol Ther. 2000, 14:1319-1328.
3. Gisbert J.P., Pajares J.M. Review article: Helicobacter pylori "rescue" regimen when proton pump inhibitor-based triple therapies fail. Aliment Pharmacol Ther. 2002, 16:1047-1057.
4. Gisbert J.P., Pajares R., Pajares J.M. Evolution of Helicobacter pylori therapy from a meta-analytical perspective. Helicobacter. 2007, 12(Suppl 2):50-58.
5. Gisbert J.P. Rescue" regimens after Helicobacter pylori treatment failure. World J Gastroenterol. 2008, 14:5385-5402.
6. Megraud F. H pylori antibiotic resistance:prevalence, importance, and advances in testing. Gut. 2004, 53:1374-1384.
7. Gisbert J.P., Pajares J.M. Helicobacter pylori "rescue" therapy after failure of two eradication treatments. Helicobacter. 2005, 10:363-372.
8. Zullo A., Hassan C., Lorenzetti R., Winn S., Morini S. A clinical practice viewpoint: to culture or not to culture Helicobacter pylori?. Dig Liver Dis. 2003, 35:357-361.
9. Yahav J., Samra Z., Niv Y., Evans C.T., Passaro D.J., Dinari G., et al. Susceptibility-guided vs. empiric retreatment of Helicobacter pylori infection after treatment failure. Dig Dis Sci. 2006, 51:2316-2321.
10. Avidan B., Melzer E., Keller N., Bar-Meir S. The effect of culture results for Helicobacter pylori on the choice of treatment following failure of initial eradication. Isr Med Assoc J. 2001, 3:163-165.
11. Miwa H., Nagahara A., Kurosawa A., Ohkusa T., Ohkura R., Hojo M., et al. Is antimicrobial susceptibility testing necessary before second-line treatment for Helicobacter pylori infection?. Aliment Pharmacol Ther. 2003, 17:1545-1551.
12. Shimoyama T., Fukuda S., Mikami T., Fukushi M., Munakata A. Efficacy of metronidazole for the treatment of clarithromycin-resistant Helicobacter pylori infection in a Japanese population. J Gastroenterol. 2004, 39:927-930.
13. Nagahara A., Miwa H., Kawabe M., Kurosawa A., Asaoka D., Hojo M., et al. Second-line treatment for Helicobacter pylori infection in Japan:proton pump inhibitor-based amoxicillin and metronidazole regimen. J Gastroenterol. 2004, 39:1051-1055.
14. Murakami K., Okimoto T., Kodama M., Sato R., Watanabe K., Fujioka T. Evaluation of three different proton pump inhibitors with amoxicillin and metronidazole in retreatment for Helicobacter pylori infection. J Clin Gastroenterol. 2008, 42:139-142.
15. Shirai N., Sugimoto M., Kodaira C., Nishino M., Ikuma M., Kajimura M., et al. Dual therapy with high doses of rabeprazole and amoxicillin versus triple therapy with rabeprazole, amoxicillin, and metronidazole as a rescue regimen for Helicobacter pylori infection after the standard triple therapy. Eur J Clin Pharmacol. 2007, 63:743-749.
16. Isomoto H., Inoue K., Furusu H., Enjoji A., Fujimoto C., Yamakawa M., et al. High-dose rabeprazole-amoxicillin versus rabeprazole-amoxicillin-metronidazole as second-line treatment after failure of the Japanese standard regimen for Helicobacter pylori infection. Aliment Pharmacol Ther. 2003, 18:101-107.
17. Murakami K., Okimoto T., Kodama M., Sato R., Miyajima H., Ono M., et al. Comparison of amoxicillin-metronidazole plus famotidine or lansoprazole for amoxicillin-clarithromycin-proton pump inhibitor treatment failures for Helicobacter pylori infection. Helicobacter. 2006, 11:436-440.
18. Matsuhisa T., Kawai T., Masaoka T., Suzuki H., Ito M., Kawamura Y., et al. Efficacy of metronidazole as second-line drug for the treatment of Helicobacter pylori Infection in the Japanese population: a multicenter study in the Tokyo Metropolitan Area. Helicobacter. 2006, 11:152-158.
19. Nagahara A., Miwa H., Ohkura R., Yamada T., Sato K., Hojo M., et al. Strategy for retreatment of therapeutic failure of eradication of Helicobacter pylori infection. J Gastroenterol Hepatol. 2001, 16:613-618.
20. Gisbert J.P., Boixeda D., Bermejo F., Nieves Rincon M., Jesus Higes M., Angeles Arpa M., et al. Re-treatment after Helicobacter pylori eradication failure. Eur J Gastroenterol Hepatol. 1999, 11:1049-1054.
21. Gisbert J.P., Calvet X., Gomollon F., Sainz R. Treatment for the eradication of Helicobacter pylori. Recommendations of the Spanish Consensus Conference. Med Clin (Barc). 2000, 114:185-195.
22. Gisbert J.P., Gisbert J.L., Marcos S., Gravalos R.G., Carpio D., Pajares J.M., Seven-day 'rescue' therapy after Helicobacter pylori treatment failure:omeprazole, bismuth, tetracycline and metronidazole vs. ranitidine bismuth citrate, tetracycline and metronidazole. Aliment Pharmacol Ther. 1999, 13:1311-1316.
23. Choung R.S., Lee S.W., Jung S.W., Han W.S., Kim M.J., Jeen Y.T., et al. Comparison of the effectiveness of quadruple salvage regimen for Helicobacter pylori infection according to the duration of treatment. Korean J Gastroenterol. 2006, 47:131-135.
24. de Boer W.A., Driessen W.M., Potters V.P., Tytgat G.N. Randomized study comparing 1 with 2 weeks of quadruple therapy for eradicating Helicobacter pylori. Am J Gastroenterol. 1994, 89:1993-1997.
25. Lee BH, Kim N, Hwang TJ, Lee SH, Park YS, Hwang JH, et al. Bismuth-containing quadruple therapy as second-line treatment for Helicobacter pylori infection: effect of treatment duration and antibiotic resistance on the eradication rate in Korea. Helicobacter. ;15:38-45.
26. Gomollon F., Valdeperez J., Garuz R., Fuentes J., Barrera F., Malo J., et al. Análisis coste-efectividad de dos estrategias de erradicación de Helicobacter pylori: resultados de un estudio prospectivo y aleatorizado en atención primaria. Med Clin (Barc). 2000, 115:1-6.
27. Marko D., Calvet X., Ducons J., Guardiola J., Tito L., Bory F. Comparison of two management strategies for Helicobacter pylori treatment: clinical study and cost-effectiveness analysis. Helicobacter. 2005, 10:22-32.
28. Gisbert J.P., Morena F. Systematic review and meta-analysis:levofloxacin-based rescue regimens after Helicobacter pylori treatment failure. Aliment Pharmacol Ther. 2006, 23:35-44.
29. Saad R.J., Schoenfeld P., Kim H.M., Chey W.D. Levofloxacin-based triple therapy versus bismuth-based quadruple therapy for persistent Helicobacter pylori infection: a meta-analysis. Am J Gastroenterol. 2006, 101:488-496.
30. Reilly T.G., Ayres R.C., Poxon V., Walt R.P. Helicobacter pylori eradication in a clinical setting:success rates and the effect on the quality of life in peptic ulcer. Aliment Pharmacol Ther. 1995, 9:483-490.
31. Lerang F., Moum B., Haug J.B., Berge T., Tolas P., Sandvei P.K., et al. Highly effective second-line anti-Helicobacter pylori therapy in patients with previously failed metronidazole-based therapy. Scand J Gastroenterol. 1997, 32:1209-1214.
32. Magaret N., Burm M., Faigel D., Kelly C., Peterson W., Fennerty M.B. A randomized trial of lansoprazole, amoxycillin, and clarithromycin versus lansoprazole, bismuth, metronidazole and tetracycline in the retreatment of patients failing initial Helicobacter pylori therapy. Dig Dis. 2001, 19:174-178.
33. Beales I.L. Efficacy of Helicobacter pylori eradication therapies: a single centre observational study. BMC Gastroenterol. 2001, 1:7.
34. Axon A.T. Treatment of Helicobacter pylori: an overview. Aliment Pharmacol Ther. 2000, 14(Suppl 3):1-6.
35. Miehlke S., Hansky K., Schneider-Brachert W., Kirsch C., Morgner A., Madisch A., et al. Randomized trial of rifabutin-based triple therapy and high-dose dual therapy for rescue treatment of Helicobacter pylori resistant to both metronidazole and clarithromycin. Aliment Pharmacol Ther. 2006, 24:395-403.
36. Gisbert J.P., Mur M., Sainz S., Cena G., Martin C., Sainz R., et al. ¿Es útil la asociación de omeprazol y amoxicilina en el tratamiento erradicador de Helicobacter pylori en España?. Rev Esp Enferm Dig. 1996, 88:99-106.
37. Cudia B., Romano M., Gioè F.P., Barbera N., Lo Gerfo D., Montalto R. Rescue" therapy including ranitidine bismuth citrate + minocicline + amoxicillin for eradication of Helicobacter pylori in previous H.P. treatment failure. Gut. 1997, 41(Suppl 1):A103.
38. Miehlke S., Kirsch C., Schneider-Brachert W., Haferland C., Neumeyer M., Bastlein E., et al. A prospective, randomized study of quadruple therapy and high-dose dual therapy for treatment of Helicobacter pylori resistant to both metronidazole and clarithromycin. Helicobacter. 2003, 8:310-319.
39. Chi C.H., Lin C.Y., Sheu B.S., Yang H.B., Huang A.H., Wu J.J. Quadruple therapy containing amoxicillin and tetracycline is an effective regimen to rescue failed triple therapy by overcoming the antimicrobial resistance of Helicobacter pylori. Aliment Pharmacol Ther. 2003, 18:347-353.
40. Zullo A., Hassan C., De Francesco V., Lorenzetti R., Marignani M., Angeletti S., et al. A third-line levofloxacin-based rescue therapy for Helicobacter pylori eradication. Dig Liver Dis. 2003, 35:232-236.
41. Gisbert J.P., Gisbert J.L., Marcos S., Moreno-Otero R., Pajares J.M. Third-line rescue therapy with levofloxacin is more effective than rifabutin rescue regimen after two Helicobacter pylori treatment failures. Aliment Pharmacol Ther. 2006, 24:1469-1474.
42. Akada J.K., Shirai M., Fujii K., Okita K., Nakazawa T. In vitro anti-Helicobacter pylori activities of new rifamycin derivatives. KRM-1648 and KRM-1657. Antimicrob Agents Chemother. 1999, 43:1072-1076.
43. Heep M., Beck D., Bayerdorffer E., Lehn N. Rifampin and rifabutin resistance mechanism in Helicobacter pylori. Antimicrob Agents Chemother. 1999, 43:1497-1499.
44. Brogden R.N., Fitton A. Rifabutin. A review of its antimicrobial activity, pharmacokinetic properties and therapeutic efficacy. Drugs. 1994, 47:983-1009.
45. Perri F., Festa V., Clemente R., Villani M.R., Quitadamo M., Caruso N., et al. Randomized study of two "rescue" therapies for Helicobacter pylori- infected patients after failure of standard triple therapies. Am J Gastroenterol. 2001, 96:58-62.
46. Gonzalez Carro P., Perez Roldan F., De Pedro Esteban A., Legaz Huidobro M.L., Soto Fernandez S., Roncero Garcia Escribano O., et al. Efficacy of rifabutin-based triple therapy in Helicobacter pylori infected patients after two standard treatments. J Gastroenterol Hepatol. 2007, 22:60-63.
47. Gisbert J.P., Calvet X., Bujanda L., Marcos S., Gisbert J.L., Pajares J.M. 'Rescue' therapy with rifabutin after multiple Helicobacter pylori treatment failures. Helicobacter. 2003, 8:90-94.
48. Treiber G., Ammon S., Malfertheiner P., Klotz U. Impact of furazolidone-based quadruple therapy for eradication of Helicobacter pylori after previous treatment failures. Helicobacter. 2002, 7:225-231.
49. Buzas G.M., Jozan J. Nitrofuran-based regimens for the eradication of Helicobacter pylori infection. J Gastroenterol Hepatol. 2007, 22:1571-1581.
50. Seppala K., Kosunen T.U., Nuutinen H., Sipponen P., Rautelin H., Sarna S., et al. Cure of Helicobacter pylori infection after failed primary treatment:one-center results from 120 patients. Scand J Gastroenterol. 2000, 35:929-934.
51. Gisbert J.P. Rescue therapy with levofloxacin after multiple H. pylori treatment failures. Aliment Pharmacol Ther. 2005, 22:653-654. author reply 654-655.
52. Gisbert J.P., Gisbert J.L., Marcos S., Jimenez-Alonso I., Moreno-Otero R., Pajares J.M. Empirical rescue therapy after Helicobacter pylori treatment failure: a 10-year single-centre study of 500 patients. Aliment Pharmacol Ther. 2008, 27:346-354.
53. Gisbert J.P. The attitude in a failure to eradicate Helicobacter pylori: surrender or fight?. Med Clin (Barc). 1998, 111:778-782.